In the News: June 2021 Regulatory and Development Updates
Camargo
JULY 8, 2021
Researchers at the Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have observed that MAOIs might help the immune system attack cancer. The FDA itself did not produce the assessment but instead contracted the Eastern Research Group to conduct the assessment and produce a report. . ” .
130 
Let's personalize your content